This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Necrotizing enterocolitis (NEC) is a serious medical condition most commonly affecting premature babies. It is a type of intestinal inflammation that results in damage to the wall of the intestine. NEC is most commonly seen in premature babies and is often fatal. NEC usually starts with a bacterial infection in the intestine. This bacteria affects the lining of the intestine, resulting in inflammation and damage. This can cause the intestine to become blocked or can cause the intestine to rupture. NEC can also be caused by an insufficient blood supply to the intestine, due to immature blood vessels. The main symptoms of NEC are abdominal distension, vomiting and bloody stools. Other signs include decreased activity, poor feeding, and fever. In severe cases, NEC can cause shock, sepsis and death. Diagnosis is usually made through physical exam and imaging, such as X-rays or ultrasound. Treatment for NEC depends on the severity of the condition and can include antibiotics, fluids, enteral nutrition, and surgery. In severe cases, a complete bowel resection may be necessary. NEC is a serious medical condition and can be life-threatening. It is important that premature babies are monitored closely and that medical attention is sought at the first sign of NEC. Early diagnosis and treatment can help to reduce the risk of serious complications and death.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States